Evaluation of Safety of Treatment With Anti–Epidermal Growth Factor Receptor Antibody Drug Conjugate MRG003 in Patients With Advanced Solid TumorsMiao‐Zhen Qiu, Rui‐Hua Xu, Yang Zhang et al.|JAMA Oncology|2022Cited by 69
Association of Plasma Epstein-Barr Virus DNA With Outcomes for Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma Receiving Anti–Programmed Cell Death 1 ImmunotherapyJianying Xu, Feng‐Hua Wang, Xiaoli Wei et al.|JAMA Network Open|2022Cited by 64
A phase I study of toripalimab, an anti‐PD‐1 antibody, in patients with refractory malignant solid tumorsXiaoli Wei, Rui‐Hua Xu, Chao Ren et al.|Cancer Communications|2020Cited by 54
A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphomaYuankai Shi, Xin Zhang, Yu Yang et al.|Journal of Hematology & Oncology|2020Cited by 50
Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2+ Cytotoxic T Cells and Favorable Prognosis in Lung AdenocarcinomaFanfan Fan, Haiquan Chen, Jian Gao et al.|Cancer Research|2023Cited by 40